CLX Financials Clorox

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated 41 d ago Overview →

Growth & profitability

Revenue has grown 1.1% per year over the past 5 years.
Net income has grown slower than revenue (-2.9% vs 1.1% per year).
Free cash flow has declined 10.0% per year over the past 5 years.

Financial health

Total debt ($2.5B) exceeds cash ($167M); net debt is $2.3B.
Total debt has grown slower than revenue (-2.2% vs 1.1% per year).

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 74.3% of earnings and 79.1% of free cash flow.
The dividend has grown 2.5% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$7.1B	$810M	45.2%	0.0%	252.3%	14.6%	$761M	$2.5B	$167M
2024	$7.1B	$280M	43.0%	0.0%	85.4%	4.9%	$483M	$2.5B	$202M
2023	$7.4B	$149M	39.4%	0.0%	67.7%	2.5%	$930M	$2.5B	$367M
2022	$7.1B	$462M	35.8%	0.0%	83.1%	7.5%	$535M	$2.7B	$183M
2021	$7.3B	$710M	43.6%	0.0%	172.7%	11.2%	$945M	$2.8B	$319M
2020	$6.7B	$939M	45.6%	0.0%	103.4%	15.1%	$1.3B	$2.8B	$871M
2019	$6.2B	$820M	43.9%	0.0%	146.7%	16.0%	$786M	$2.7B	$111M
2018	—	$823M	—	—	113.4%	16.3%	$782M	$2.5B	$131M
2017	—	$701M	—	—	129.3%	15.3%	$634M	$2.2B	$418M
2016	—	$648M	—	—	218.2%	14.4%	$606M	$2.3B	$401M
2015	—	$580M	—	—	491.5%	14.0%	$749M	$2.2B	$382M
2014	—	$558M	—	—	362.3%	13.1%	$630M	$2.3B	$329M
2013	—	$572M	—	—	391.8%	13.3%	$585M	$2.4B	$299M
2012	—	$541M	—	—	-400.7%	12.4%	$423M	$2.7B	$267M
2011	—	$557M	—	—	-647.7%	13.4%	$470M	$2.6B	$259M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Mar '26	$1.7B	$187M	43.2%	0.0%	-279.1%	2.9%	-$165M	$4.1B	$1.2B
Dec '25	$1.7B	$157M	43.2%	0.0%	-125.6%	2.8%	$269M	$2.8B	$227M
Sep '25	$1.4B	$80M	41.7%	0.0%	-363.6%	1.4%	$57M	$2.7B	$166M
Jun '25	$2.0B	$332M	46.5%	0.0%	103.4%	6.0%	$219M	$2.5B	$167M
Mar '25	$1.7B	$186M	44.6%	0.0%	688.9%	3.4%	$233M	$2.5B	$226M
Dec '24	$1.7B	$193M	43.8%	0.0%	-470.7%	3.5%	$127M	$2.7B	$290M
Sep '24	$1.8B	$99M	45.8%	0.0%	165.0%	1.8%	$182M	$2.5B	$278M
Jun '24	$1.9B	$216M	46.5%	0.0%	65.9%	3.8%	$259M	$2.5B	$202M
Mar '24	$1.8B	-$51M	42.2%	0.0%	-56.0%	-0.9%	$127M	$2.6B	$219M
Dec '23	$2.0B	$93M	43.5%	0.0%	175.5%	1.6%	$101M	$2.7B	$355M
Sep '23	$1.4B	$22M	38.4%	0.0%	-59.5%	0.4%	-$4M	$2.8B	$518M
Jun '23	$2.0B	$176M	42.7%	0.0%	80.0%	3.0%	$346M	$2.5B	$367M
Mar '23	$1.9B	-$211M	41.8%	0.0%	-7033.3%	-3.6%	$285M	$2.6B	$242M
Dec '22	$1.7B	$99M	36.2%	0.0%	30.8%	1.6%	$167M	$2.7B	$168M
Sep '22	$1.7B	$85M	36.0%	0.0%	26.1%	1.4%	$132M	$2.8B	$278M
Jun '22	$1.8B	$101M	37.1%	0.0%	18.2%	1.6%	$256M	$2.7B	$183M
Mar '22	$1.8B	$150M	35.9%	0.0%	37.5%	2.4%	$166M	$2.9B	$241M
Dec '21	$1.7B	$69M	33.0%	0.0%	22.0%	1.1%	$124M	$2.9B	$192M
Sep '21	$1.8B	$142M	37.1%	0.0%	38.6%	2.3%	-$11M	$2.9B	$210M
Jun '21	$1.8B	$97M	37.1%	0.0%	23.6%	1.5%	$284M	$2.8B	$319M

Valuation over time

How the market has priced CLX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has fallen from 41.4× (Mar '23) to 14.1× (Sep '26).
The price-to-sales ratio has fallen from 2.7× (Mar '23) to 1.6× (Sep '26).
The dividend yield has risen from 3.0% (Mar '23) to 5.3% (Sep '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is CLX growing its revenue and profit?

Over the past 5 years, Clorox's revenue has grown 1.1% per year, and net income declined 2.9% per year. These are computed facts, not advice.

How much debt does CLX have?

As of FY2025, Clorox reported $2.5B of total debt against $167M of cash.

What is CLX's profit margin?

In FY2025, gross margin was 45.2%, operating margin —, and net margin 11.4%.

What is CLX's P/E ratio?

As of Sep '26, Clorox traded at a price-to-earnings ratio of about 14.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.